ADORA2A and neoplasm: From simulationsof the tumor volume over 30 days with dosing of the generated A2AR inhibitors and a PD-L1 mAb, the 90% prediction intervaland mean prediction of the typical individual were plotted for eachof the scenarios (Figure C).